Healthcare innovator and hedge fund strategist with background in economics/finance and biomedical science

Ronen is an expert in finance with over 25 years’ investment experience and a background in bioengineering & biomedical engineering. Founder of disruptive oncology company BioConvergent Health, which combines innovative drug and device approaches in the treatment of cancer. Ronen retains a senior advisory role at AQR Capital Management, where he was formerly principal and senior portfolio manager. A lecturer at Yale, he has published and taught extensively on finance and investing, specializing in portfolio management and hedge fund strategies